Pacira BioSciences, Inc. (PCRX) vs Seaport Therapeutics, Inc. Common Stock (SPTX)
A side-by-side comparison of Pacira BioSciences, Inc. and Seaport Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
PCRX
Pacira BioSciences, Inc.
$24.71HealthcareDelayed quote: Oct 6, 2026, 1:40 PM EDT
SPTX
Seaport Therapeutics, Inc. Common Stock
$17.75HealthcareDelayed quote: Oct 6, 2026, 1:39 PM EDT
Total return — PCRX vs SPTX
growth of $100 · dividends reinvested · last 1yPCRX +2.5% (+2.5%/yr)SPTX -6.8% (-6.8%/yr)PCRX compounded faster over this window
PCRX SPTX
PCRX vs SPTX: by the numbers
- •PCRX is the larger company ($972M vs $950M market cap).
- •PCRX is profitable (1.96% net margin) while SPTX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | PCRX | SPTX |
|---|---|---|
| P/E ratio | 70.34 | N/A |
| P/S ratio | 1.30 | N/A |
| P/B ratio | 1.45 | 2.25 |
| EV / EBITDA | 11.37 | N/A |
| FCF yield | 18.47% | N/A |
Profitability
| Metric | PCRX | SPTX |
|---|---|---|
| Gross margin | 79.21% | 0.00% |
| Operating margin | 2.47% | 0.00% |
| Net margin | 1.96% | 0.00% |
| ROE | 2.18% | N/A |
| ROIC | 1.35% | -36.95% |
Growth (annualized)
| Metric | PCRX | SPTX |
|---|---|---|
| Revenue CAGR (5Y) | 8.20% | N/A |
| EPS CAGR (5Y) | -45.77% | N/A |
| FCF CAGR (5Y) | 16.72% | N/A |
| Total return CAGR (5Y) | -12.27% | N/A |
Frequently asked
- Is PCRX or SPTX more profitable?
- PCRX runs the higher net margin — PCRX at 1.96% versus SPTX at 0.00%.
Go deeper
Dig into the metrics
Pacira BioSciences P/E ratioPacira BioSciences ROESeaport Therapeutics, Inc. Common Stock ROEPacira BioSciences operating marginSeaport Therapeutics, Inc. Common Stock operating marginPacira BioSciences revenue growthSeaport Therapeutics, Inc. Common Stock revenue growthPacira BioSciences free cash flowSeaport Therapeutics, Inc. Common Stock free cash flow
Pacira BioSciences & Seaport Therapeutics, Inc. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.